e-learning
resources
Conferences
Sleep and Breathing Conferences 2015-2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular effects of oral appliance treatment
Peter J. Wijkstra
Source:
5th Sleep and Breathing Conference
Number:
82
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Peter J. Wijkstra. Cardiovascular effects of oral appliance treatment. 5th Sleep and Breathing Conference
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Update on oral appliance therapy
Source: Eur Respir Rev, 28 (153) 190083; 10.1183/16000617.0083-2019
Year: 2019
Oral appliance treatment – status praesens
Source: 5th Sleep and Breathing Conference
Year: 2019
Cardiovascular adverse effects during itraconazole therapy
Source: Eur Respir J 2008; 32: 240
Year: 2008
Drug-induced sleep endoscopy predictors for oral appliance treatment outcome
Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Year: 2013
Oral appliances: from theory to practice. Recent data regarding compliance, efficacy and side-effects
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005
Effect of tezepelumab on exacerbation-related oral corticosteroid use in NAVIGATOR
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021
Cardiovascular safety of long-term therapy with combination bronchodilator in patients with stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
Long-term oral corticosteroid-sparing effects of anti-IL5/anti-IL5 receptor treatment.
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Autonomic cardiac modulation response due to the use of an oral appliance to treat OSA – Pilot study
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Weight loss and oral appliance in the treatment of snoring patients
Source: Eur Respir J 2003; 22: Suppl. 45, 96s
Year: 2003
Clinical efficacy of oral sildenafil therapy in the treatment of pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007
Asthma and hayfever is associated with use of oral contraceptives and hormonal replacement therapy
Source: Annual Congress 2003 - Risk factors for asthma
Year: 2003
Patient-reported side effects of oral corticosteroids
Source: International Congress 2018 – Medical education via the web and the internet
Year: 2018
Osteoporosis in patients with long-term inhaled corticosteroids treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 613s
Year: 2007
Cardiovascular effects of oral appliance therapy in obstructive sleep apnea: a systematic review and meta-analysis
Source: International Congress 2017 – CPAP therapy
Year: 2017
Alternatives for OSAHS treatment: selection of patients for upper airway surgery and oral appliances
Source: Eur Respir Rev 2007; 16: 132-145
Year: 2007
One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 618s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept